Five Prime Therapeutics Inc (NASDAQ:FPRX)

16.04
Delayed Data
As of 4:00pm ET
 -0.84 / -4.98%
Today’s Change
15.66
Today|||52-Week Range
48.87
-26.82%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 49.00, with a high estimate of 65.00 and a low estimate of 25.00. The median estimate represents a +205.49% increase from the last price of 16.04.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.12
Sales
$9.6M
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.21%
 
 
 
 
 
 
Growthannually 24.95%
 
 
 
 
 
 

Sales

Growthquarterly -27.37%
 
 
 
 
 
 
Growthannually 90.53%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.